Take home messages and a near future roadmap for optimizing new oral anticoagulant-based stroke prevention in atrial fibrillation management: from risk to remedy.

About the speaker

Professor Ajay Kakkar

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)
13 presentations
0 follower

4 more presentations in this session

Clinical dilemmas in stroke prevention for atrial fibrillation: trials to translation — Current status.

Speaker: Doctor S. Goldhaber (Boston, US)

Thumbnail

Evolving challenges on the therapeutic landscape for stroke prevention in atrial fibrillation: what do the trials and guidelines teach us?

Speaker: Professor J. Camm (London, GB)

Thumbnail

Optimizing SPAF management in AF patients with history of stroke or TIA: approaches to acute and long-term treatment with NOACs in patients with AF-associated cerebral thrombosis.

Speaker: Professor W. Hacke

Thumbnail

Decision making in AF patients requiring anticoagulation: who are the best candidates for NOACs ?

Speaker: Professor J. Le Heuzey (Paris, FR)

Thumbnail

Access the full session

New frontiers and treatment paradigms for stroke prevention in atrial fibrillation: translating landmark trials, ESC Guidelines, and expert-based analysis to the front lines of cardiovascular care for patients with nonvalvular atrial fibrillation

Speakers: Professor A. Kakkar, Doctor S. Goldhaber, Professor J. Camm, Professor W. Hacke, Professor J. Le Heuzey
Thumbnail

About the event

Image

ESC Congress 2013

31 August - 4 September 2013

Sessions Presentations